Fareva to buy Pfizer plant to build US pharma presence

- Last updated on GMT

US drug giant Pfizer is to sell its plant in Henrico County, Virginia to Luxembourg-headquartered manufacturer Fareva.

News of the acquisition, detailed in a press statement by Virginian Governor Bob McDonnell, is a reprive for the facility and its 500-strong workforce, which was earmarked for closure in 2010 as part of Pfizer’s effort to reduce manufacturing capacity.

Fareva CEO Bernard Fraisse said: “We have been looking for the right opportunity to expand our manufacturing footprint into North America and establish our pharmaceutical and cosmetics businesses in the US.”

Fareva, which employs 5,500 people at 28 facilities across Europe, also said it plans to invest $43m in the site and create around 90 new manufacturing jobs.

Related news

Show more

Related products

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Related suppliers